Steroids for PML-IRIS: a double-edged sword?
Berger
Joseph R
JR
D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000188:drug therapy* / Q000276:immunology* / Q000503:physiopathology; D007107:Immune System / Q000187:drug effects / Q000276:immunology; D007165:Immunosuppression Therapy / Q000009:adverse effects / Q000379:methods*; D007249:Inflammation / Q000139:chemically induced / Q000503:physiopathology / Q000821:virology; D007577:JC Virus / Q000187:drug effects / Q000276:immunology; D007968:Leukoencephalopathy, Progressive Multifocal / Q000188:drug therapy* / Q000276:immunology* / Q000503:physiopathology; D018570:Risk Assessment
D000305:Adrenal Cortex Hormones